相似文献
1
The Effect of Menopausal Status, Age, and Human Immunodeficiency Virus (HIV) on Non-AIDS Comorbidity Burden Among US Women.
Clin Infect Dis. 2023 Feb 8;76(3):e755-e758. doi: 10.1093/cid/ciac465.
2
Human immunodeficiency virus and menopause.
Menopause. 2013 Sep;20(9):983-90. doi: 10.1097/GME.0b013e318282aa57.
3
Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.
Clin Infect Dis. 2021 Oct 5;73(7):e2059-e2069. doi: 10.1093/cid/ciaa1928.
4
Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019.
JAMA Netw Open. 2023 Aug 1;6(8):e2327584. doi: 10.1001/jamanetworkopen.2023.27584.
5
The Prevalence and Burden of Non-AIDS Comorbidities Among Women Living With or at Risk for Human Immunodeficiency Virus Infection in the United States.
Clin Infect Dis. 2021 Apr 26;72(8):1301-1311. doi: 10.1093/cid/ciaa204.
6
Use of antimüllerian hormone to predict the menopausal transition in HIV-infected women.
Am J Obstet Gynecol. 2017 Jan;216(1):46.e1-46.e11. doi: 10.1016/j.ajog.2016.07.048. Epub 2016 Jul 26.
7
Clinical considerations for menopause and associated symptoms in women with HIV.
Menopause. 2023 Mar 1;30(3):329-331. doi: 10.1097/GME.0000000000002146.
8
How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort.
BMC Womens Health. 2021 May 28;21(1):223. doi: 10.1186/s12905-021-01370-w.
9
Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency Virus.
Clin Infect Dis. 2023 Jul 26;77(2):265-271. doi: 10.1093/cid/ciad165.
10
Menopausal symptoms are associated with non-adherence to highly active antiretroviral therapy in human immunodeficiency virus-infected middle-aged women.
Climacteric. 2020 Jun;23(3):229-236. doi: 10.1080/13697137.2019.1664457. Epub 2019 Dec 6.
引用本文的文献
1
Being in postmenopause may be associated with lower prevalence of COVID-19 symptoms among women over 45 years of age with and without HIV.
Menopause. 2025 Jul 22. doi: 10.1097/GME.0000000000002618.
2
A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.
Curr HIV/AIDS Rep. 2025 Jun 26;22(1):39. doi: 10.1007/s11904-025-00743-2.
3
Menopause: an opportunity to optimize health and well being for people with HIV.
Curr Opin HIV AIDS. 2025 Jul 1;20(4):388-395. doi: 10.1097/COH.0000000000000944. Epub 2025 Apr 21.
4
The impact of sex on HIV immunopathogenesis and therapeutic interventions.
J Clin Invest. 2024 Sep 17;134(18):e180075. doi: 10.1172/JCI180075.
5
Centring the health of women across the HIV research continuum.
Lancet HIV. 2024 Mar;11(3):e186-e194. doi: 10.1016/S2352-3018(24)00004-3.
6
Body Composition Changes Over the Menopausal Transition in Women With and Without Human Immunodeficiency Virus.
Clin Infect Dis. 2023 Jul 26;77(2):265-271. doi: 10.1093/cid/ciad165.
7
Cumulative Human Immunodeficiency Virus (HIV)-1 Viremia Is Associated With Increased Risk of Multimorbidity Among US Women With HIV, 1997-2019.
Open Forum Infect Dis. 2022 Dec 28;10(2):ofac702. doi: 10.1093/ofid/ofac702. eCollection 2023 Feb.
8
Bone, Brain, Heart study protocol: A resilient nested, tripartite prospective cohort study of the role of estrogen depletion on HIV pathology.
PLoS One. 2022 Aug 3;17(8):e0272608. doi: 10.1371/journal.pone.0272608. eCollection 2022.
本文引用的文献
1
The Reproductive Transition: Effects on Viral Replication, Immune Activation, and Metabolism in Women with HIV infection.
Curr HIV/AIDS Rep. 2022 Feb;19(1):133-139. doi: 10.1007/s11904-021-00594-7. Epub 2021 Dec 8.
2
Predictors of low ovarian reserve in cART-treated women living with HIV.
Medicine (Baltimore). 2021 Oct 1;100(39):e27157. doi: 10.1097/MD.0000000000027157.
3
Menopause Is Associated With Immune Activation in Women With HIV.
J Infect Dis. 2022 Jan 18;225(2):295-305. doi: 10.1093/infdis/jiab341.
4
Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.
Clin Infect Dis. 2021 Oct 5;73(7):e2059-e2069. doi: 10.1093/cid/ciaa1928.
5
Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
Circulation. 2020 Dec 22;142(25):e506-e532. doi: 10.1161/CIR.0000000000000912. Epub 2020 Nov 30.
6
Bearing the Burden of Non-AIDS Comorbidities: This Is What Women Aging With Human Immunodefiency Virus Look Like.
Clin Infect Dis. 2021 Apr 26;72(8):1312-1313. doi: 10.1093/cid/ciaa209.
7
The Prevalence and Burden of Non-AIDS Comorbidities Among Women Living With or at Risk for Human Immunodeficiency Virus Infection in the United States.
Clin Infect Dis. 2021 Apr 26;72(8):1301-1311. doi: 10.1093/cid/ciaa204.
8
The menopause transition in women living with HIV: current evidence and future avenues of research.
J Virus Erad. 2016 Apr 1;2(2):114-6. doi: 10.1016/S2055-6640(20)30476-3.
9
Use of antimüllerian hormone to predict the menopausal transition in HIV-infected women.
Am J Obstet Gynecol. 2017 Jan;216(1):46.e1-46.e11. doi: 10.1016/j.ajog.2016.07.048. Epub 2016 Jul 26.
10
Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV.
AIDS. 2016 Jan 28;30(3):383-93. doi: 10.1097/QAD.0000000000000902.
Zotero 插件